Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

Detalles Bibliográficos
Autores principales: Gaule, Marina, Pesoni, Camilla, Quinzii, Alberto, Zecchetto, Camilla, Casalino, Simona, Merz, Valeria, Contarelli, Serena, Pietrobono, Silvia, Vissio, Elena, Molinaro, Luca, Manzin, Enrica, Volpatto, Roberta, Vellani, Giorgio, Melisi, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769132/
https://www.ncbi.nlm.nih.gov/pubmed/35005993
http://dx.doi.org/10.1200/PO.21.00400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769132/
https://www.ncbi.nlm.nih.gov/pubmed/35005993
http://dx.doi.org/10.1200/PO.21.00400

Ejemplares similares